UNIVERSITY OF CO HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $20.9M
- Transactions
- 1,265
- Companies
- 40
- Average per transaction
- $16,514
Who reported the payments
| E.r. Squibb & Sons, L.L.C. | $4,825,759 |
| Servier Pharmaceuticals LLC | $3,292,080 |
| AbbVie | $2,681,026 |
| Servier Bioinnovation | $2,232,153 |
| Takeda Pharmaceuticals U.S.A., Inc. | $813,367 |
| Clovis Oncology, Inc. | $538,344 |
| Haemonetics Corporation | $529,178 |
| Intuitive Surgical | $466,753 |
| Grifols Shared Services North America, Inc. | $433,118 |
| Conmed Corporation | $419,938 |
| Immunogen, Inc. | $375,688 |
| Orthofix Medical, Inc. | $373,344 |
| Pfizer | $340,371 |
| Angiodynamics, Inc. | $263,583 |
| Avita Medical Americas, LLC | $256,679 |
| Olympus Corporation | $207,019 |
| Merck | $172,796 |
| EMD Millipore Corporation | $166,437 |
| Tesaro, Inc. | $155,556 |
| Vitalant | $155,137 |
| Dexcom, Inc. | $129,035 |
| Uromedica, Incorporated | $125,856 |
| Organon | $110,267 |
| Philips North America LLC | $99,971 |
| Gilead | $90,000 |
| Medtronic | $62,619 |
| Iovance Biotherapeutics, Inc. | $61,942 |
| Skeletal Dynamics Inc | $60,250 |
| Miach Orthopaedics, Inc. | $54,901 |
| Taiho Oncology, Inc. | $52,092 |
| US Endoscopy | $51,283 |
| Amylyx Pharmaceuticals, Inc. | $51,114 |
| Biocryst Pharmaceuticals, Inc. | $50,801 |
| Aesculap Biologics, LLC | $50,515 |
| National Marrow Donor Program | $47,245 |
| Paragon 28, Inc. | $39,776 |
| Eli Lilly | $37,389 |
| Exactech, Inc. | $37,130 |
| Kls-martin L.p. | $36,880 |
| Roche Molecular Systems, Inc. | $34,824 |